MX360801B - Formas solidas de moduladores selectivos de receptor de androgenos. - Google Patents
Formas solidas de moduladores selectivos de receptor de androgenos.Info
- Publication number
- MX360801B MX360801B MX2017007289A MX2017007289A MX360801B MX 360801 B MX360801 B MX 360801B MX 2017007289 A MX2017007289 A MX 2017007289A MX 2017007289 A MX2017007289 A MX 2017007289A MX 360801 B MX360801 B MX 360801B
- Authority
- MX
- Mexico
- Prior art keywords
- solid forms
- androgen receptor
- receptor modulators
- selective androgen
- selective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a uso de la forma cristalina D de (R) o (S)-N-(4-ciano-3-(trifluorometil)fenil)-3-(4-cianofenoxi) -2-hidroxi-2-metilpropanamida, en la preparación de un medicamento para tratar una condición relacionada con hormonas seleccionada de la disminución de andrógenos en el hombre adulto (ADAM), disminución de andrógenos en las mujeres (ADIF), desgaste muscular crónico y cáncer de próstata.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96001207P | 2007-09-11 | 2007-09-11 | |
PCT/US2008/076066 WO2009036206A1 (en) | 2007-09-11 | 2008-09-11 | Solid forms of selective androgen receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX360801B true MX360801B (es) | 2018-11-16 |
Family
ID=40452483
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010002784A MX2010002784A (es) | 2007-09-11 | 2008-09-11 | Formas solidas de moduladores selectivos del receptor de androgenos. |
MX2017007289A MX360801B (es) | 2007-09-11 | 2008-09-11 | Formas solidas de moduladores selectivos de receptor de androgenos. |
MX2016010097A MX351941B (es) | 2007-09-11 | 2008-09-11 | Formas sólidas de moduladores selectivos de receptor de andrógenos. |
MX2012013650A MX341090B (es) | 2007-09-11 | 2008-09-11 | Formas solidas de moduladores selectivos de receptor de androgenos. |
MX2012013653A MX336760B (es) | 2007-09-11 | 2008-09-11 | Formas solidas de moduladores selectivos de receptor de androgenos. |
MX2018014065A MX2018014065A (es) | 2007-09-11 | 2010-03-11 | Formas solidas de moduladores selectivos de receptor de androgenos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010002784A MX2010002784A (es) | 2007-09-11 | 2008-09-11 | Formas solidas de moduladores selectivos del receptor de androgenos. |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016010097A MX351941B (es) | 2007-09-11 | 2008-09-11 | Formas sólidas de moduladores selectivos de receptor de andrógenos. |
MX2012013650A MX341090B (es) | 2007-09-11 | 2008-09-11 | Formas solidas de moduladores selectivos de receptor de androgenos. |
MX2012013653A MX336760B (es) | 2007-09-11 | 2008-09-11 | Formas solidas de moduladores selectivos de receptor de androgenos. |
MX2018014065A MX2018014065A (es) | 2007-09-11 | 2010-03-11 | Formas solidas de moduladores selectivos de receptor de androgenos. |
Country Status (20)
Country | Link |
---|---|
US (1) | US7977386B2 (es) |
EP (2) | EP2871177B1 (es) |
JP (3) | JP5452492B2 (es) |
KR (3) | KR20170001736A (es) |
CN (3) | CN103073450B (es) |
AU (1) | AU2008298901C1 (es) |
CA (3) | CA2886501C (es) |
CY (1) | CY1120107T1 (es) |
DK (1) | DK2205552T3 (es) |
EA (1) | EA018611B1 (es) |
ES (1) | ES2665007T3 (es) |
HR (1) | HRP20180500T1 (es) |
HU (1) | HUE036762T2 (es) |
IL (2) | IL204352A (es) |
LT (1) | LT2205552T (es) |
MX (6) | MX2010002784A (es) |
NO (1) | NO2205552T3 (es) |
PL (1) | PL2205552T3 (es) |
PT (1) | PT2205552T (es) |
WO (1) | WO2009036206A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US7855229B2 (en) * | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
US8853266B2 (en) * | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
US20110237664A1 (en) * | 2004-06-07 | 2011-09-29 | Dalton James T | Selective androgen receptor modulators for treating diabetes |
US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
US7968603B2 (en) * | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
CN103073450B (zh) * | 2007-09-11 | 2014-12-03 | Gtx公司 | 选择性雄激素受体调节剂的固体形态 |
EP2523556A4 (en) * | 2010-01-11 | 2013-08-28 | Gtx Inc | METHOD FOR TREATING MIBROMED DYNAMIC FUNCTION |
US10314807B2 (en) | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US10987334B2 (en) | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
PT2872482T (pt) | 2012-07-13 | 2020-09-22 | Oncternal Therapeutics Inc | Método de tratamento de cancro de mama com modulador seletivo do recetor de andrógeno (sarm) |
US9969683B2 (en) | 2012-07-13 | 2018-05-15 | Gtx, Inc. | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) |
US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
CN110563607B (zh) * | 2019-10-25 | 2022-07-08 | 许昌远志生物科技有限公司 | 一种mk-2866的精制方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050038110A1 (en) | 2000-08-24 | 2005-02-17 | Steiner Mitchell S. | Selective androgen receptor modulators and methods of use thereof |
US7622503B2 (en) | 2000-08-24 | 2009-11-24 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US7026500B2 (en) * | 2000-08-24 | 2006-04-11 | University Of Tennessee Research Foundation | Halogenated selective androgen receptor modulators and methods of use thereof |
US7919647B2 (en) | 2000-08-24 | 2011-04-05 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and methods of use thereof |
US20070173546A1 (en) * | 2000-08-24 | 2007-07-26 | Dalton James T | Selective androgen receptor modulators and method of use thereof |
US7645898B2 (en) * | 2000-08-24 | 2010-01-12 | University Of Tennessee Research Foundation | Selective androgen receptor modulators and method of use thereof |
JP2004518617A (ja) * | 2000-08-24 | 2004-06-24 | ザ・ユニバーシティ・オブ・テネシー・リサーチ・コーポレーション | 選択的アンドロゲン受容体モジュレーター及びその使用方法 |
US7855229B2 (en) | 2000-08-24 | 2010-12-21 | University Of Tennessee Research Foundation | Treating wasting disorders with selective androgen receptor modulators |
IL155041A0 (en) * | 2000-09-21 | 2003-10-31 | Bristol Myers Squibb Co | Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds |
ATE526959T1 (de) * | 2001-12-06 | 2011-10-15 | Gtx Inc | Behandlung von muskelschwund mit selektiven androgenrezeptormodulatoren |
US8853266B2 (en) | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
US20070161608A1 (en) * | 2001-12-06 | 2007-07-12 | Dalton James T | Selective androgen receptor modulators for treating muscle wasting |
ES2528764T3 (es) * | 2002-02-28 | 2015-02-12 | University Of Tennessee Research Foundation | Moduladores selectivos multisustituidos del receptor de andrógeno y métodos de uso de los mismos |
CA2502209A1 (en) * | 2002-10-15 | 2004-04-29 | University Of Tennessee Research Foundation | Methylene-bridged selective androgen receptor modulators and methods of use thereof |
CN1826313B (zh) * | 2003-01-13 | 2010-12-08 | Gtx公司 | 选择性雄激素受体调节剂的大规模合成 |
AU2004281708B2 (en) | 2003-10-14 | 2011-02-17 | University Of Tennessee Research Foundation | Treating bone-related disorders with selective androgen receptor modulators |
EP2425715B1 (en) | 2005-08-31 | 2014-03-05 | University of Tennessee Research Foundation | Treating symptoms of renal disease with selective androgen receptor modulators (SARM) |
TW200730505A (en) | 2005-12-07 | 2007-08-16 | Merck & Co Inc | Polymorphs of an androgen receptor modulator |
CN1825959A (zh) * | 2006-03-02 | 2006-08-30 | 复旦大学 | 一种基于自适应多步搜索的图像跟踪算法 |
CN103073450B (zh) * | 2007-09-11 | 2014-12-03 | Gtx公司 | 选择性雄激素受体调节剂的固体形态 |
US7968603B2 (en) * | 2007-09-11 | 2011-06-28 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
-
2008
- 2008-09-11 CN CN201210530104.4A patent/CN103073450B/zh active Active
- 2008-09-11 MX MX2010002784A patent/MX2010002784A/es active IP Right Grant
- 2008-09-11 LT LTEP08799476.0T patent/LT2205552T/lt unknown
- 2008-09-11 KR KR1020167036280A patent/KR20170001736A/ko not_active Application Discontinuation
- 2008-09-11 KR KR1020157036209A patent/KR101691877B1/ko active IP Right Grant
- 2008-09-11 CA CA2886501A patent/CA2886501C/en active Active
- 2008-09-11 EA EA201070350A patent/EA018611B1/ru not_active IP Right Cessation
- 2008-09-11 KR KR1020107007825A patent/KR101580905B1/ko active IP Right Grant
- 2008-09-11 ES ES08799476.0T patent/ES2665007T3/es active Active
- 2008-09-11 PL PL08799476T patent/PL2205552T3/pl unknown
- 2008-09-11 MX MX2017007289A patent/MX360801B/es unknown
- 2008-09-11 PT PT87994760T patent/PT2205552T/pt unknown
- 2008-09-11 JP JP2010524998A patent/JP5452492B2/ja active Active
- 2008-09-11 CA CA2886498A patent/CA2886498C/en active Active
- 2008-09-11 EP EP14190028.2A patent/EP2871177B1/en active Active
- 2008-09-11 NO NO08799476A patent/NO2205552T3/no unknown
- 2008-09-11 DK DK08799476.0T patent/DK2205552T3/en active
- 2008-09-11 CN CN201310308688.5A patent/CN103553966B/zh active Active
- 2008-09-11 CA CA2709118A patent/CA2709118C/en active Active
- 2008-09-11 WO PCT/US2008/076066 patent/WO2009036206A1/en active Application Filing
- 2008-09-11 AU AU2008298901A patent/AU2008298901C1/en active Active
- 2008-09-11 MX MX2016010097A patent/MX351941B/es unknown
- 2008-09-11 EP EP08799476.0A patent/EP2205552B1/en active Active
- 2008-09-11 MX MX2012013650A patent/MX341090B/es unknown
- 2008-09-11 MX MX2012013653A patent/MX336760B/es unknown
- 2008-09-11 CN CN2008801155337A patent/CN101855198B/zh active Active
- 2008-09-11 HU HUE08799476A patent/HUE036762T2/hu unknown
- 2008-09-11 US US12/209,137 patent/US7977386B2/en active Active
-
2010
- 2010-03-08 IL IL204352A patent/IL204352A/en active IP Right Grant
- 2010-03-11 MX MX2018014065A patent/MX2018014065A/es unknown
-
2011
- 2011-11-10 JP JP2011246394A patent/JP5599380B2/ja active Active
-
2014
- 2014-01-17 JP JP2014006976A patent/JP5727636B2/ja active Active
-
2017
- 2017-03-30 IL IL251483A patent/IL251483A0/en active IP Right Grant
-
2018
- 2018-03-27 HR HRP20180500TT patent/HRP20180500T1/hr unknown
- 2018-03-30 CY CY20181100359T patent/CY1120107T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018014065A (es) | Formas solidas de moduladores selectivos de receptor de androgenos. | |
IL242538A (en) | Composition containing (s) –n– (3– chloro – 4 – cyanophenyl) –3– (4 – cyanophenoxy) -2 | |
GEP20125586B (en) | Novel method for synthesis of (7-methoxy-l-naphthyl)-acetonitrile and application thereof in synthesis of agomelatine | |
MY156511A (en) | Compositions and devices | |
IL196627A0 (en) | Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2- | |
EP2467359A4 (en) | (BIS-) UREA- AND (BIS-) THIOMINE COMPOUNDS AS EPIGENE MODULATORS OF THE LYSINE-SPECIFIC DEMETHYLASE 1 AND METHODS OF DISEASE TREATMENT THEREWITH | |
MX2007005936A (es) | Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico. | |
SI1797037T1 (sl) | Postopek priprave 4-(4-((((4-kloro-3-(trifluorometil)fenil)amino)karbonil)amino) fenioksi)N-metilpiridin-2-karboksamida | |
EP2323667A4 (en) | MODULATION OF TRANSTHYRETIN EXPRESSION BY TREATMENT OF CNS DISEASES | |
WO2008042571A3 (en) | Substituted indole compounds | |
MX2013003309A (es) | Compuestos de benzamida sustituidos. | |
EP2379493A4 (en) | PROCESS FOR THE PREPARATION OF ASYMMETRIC BIS (THIOSEMICARBAZONES) | |
MX2010005530A (es) | Activadores de receptor de vitamina d nuevos y metodos de elaboracion de los mismos. | |
DK2166004T3 (da) | Ny fremgangsmåde til adskillelse af enantiomerer af (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitril og anvendelse heraf til syntese af ivabradin | |
HK1147267A1 (en) | Manufacture, compositions and uses of coagulationfactor viia modulator | |
ATE448234T1 (de) | Olanzapin-analoga und verfahren zu ihrer verwendung | |
HRP20130586T1 (en) | Additives for altering the hardening rate of chemically bonded silico-phosphate cements and method therefor | |
MY151100A (en) | Salts of n-[6-cis-2, 6-dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4?-(trifluoromethoxy)[1,1?-biphenyl]-3-carboxamide | |
EP1951291A4 (en) | METHOD FOR REGULATING RENALASE (MONOAMINOXIDASE C) | |
WO2010148177A3 (en) | Compounds, compositions, methods of synthesis, and methods of treatment | |
HK1131609A1 (en) | Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof | |
IL191052A0 (en) | Process for the preparation of tamsulosin and related compounds | |
GEP20094746B (en) | Use of agomelatine to obtain medication aimed at treating smith-magenis syndrome | |
ATE417816T1 (de) | Anilinohexafluoroisopropanol verbindungen | |
SI2254848T1 (sl) | Aditivi za spreminjanje hitrosti strjevanja kemično vezanih cementov na osnovi silicijevega fosfata ter ustrezen postopek |